SATL insider selling: 1,836 founders' shares proposed sale
Rhea-AI Filing Summary
Satellogic Inc. Form 144 discloses a proposed sale of 1,836 founders' common shares held since 01/26/2022, with an aggregate market value reported as $7,399.08 and an intended approximate sale date of 10/10/2025 on NASDAQ. The filing identifies Morgan Stanley Smith Barney LLC as the broker and records prior sales by the same person and under a 10b5-1 plan across August–October 2025, including a large block of 314,767 shares sold on 10/09/2025 for $1,288,844.96. The shares to be sold were acquired as founders' shares from the issuer on 01/26/2022. The filer certifies no undisclosed material adverse information and references reliance on a trading plan where applicable.
Positive
- Disclosure compliance: Proposed sale and recent 10b5-1 sales are fully disclosed in Form 144
- Broker identified: Sales are executed through Morgan Stanley Smith Barney LLC, showing use of an established broker
- Founders' shares origin disclosed: Shares to be sold were acquired as founders' shares on 01/26/2022
Negative
- Substantial recent insider selling: 314,767 shares sold on 10/09/2025 for $1,288,844.96
- Ongoing liquidation pattern: Multiple sales from 08/26/2025 through 10/09/2025 may increase available float and selling pressure
Insights
Insider filing shows planned disposal of founders' shares and recent active 10b5-1 executions.
The filing reports a proposed sale of 1,836 founders' shares acquired on 01/26/2022, with the broker listed as Morgan Stanley Smith Barney LLC and an intended sale date of 10/10/2025. The document also lists multiple prior sales under a 10b5-1 plan and open-market transactions during Aug–Oct 2025, including 314,767 shares sold on 10/09/2025 for $1,288,844.96.
These disclosures show that the holder has been actively liquidating positions recently; the most concrete monitoring point is cumulative volume and proceeds reported through 10/09/2025. Near-term attention should track any further Form 144s or Form 4 filings within the next weeks that change outstanding insider-owned share counts.
Repeated 10b5-1 and open-market sales imply routine liquidity actions, not disclosed adverse events.
The filing notes the shares to be sold were founders' shares received from the issuer, and the signer affirms no undisclosed material adverse information as of plan adoption or signing. Multiple dated sales between 08/26/2025 and 10/09/2025 are enumerated, combining plan-based and direct sales.
Governance implications center on pace and pattern of selling: investors can compare cumulative insider sales to total outstanding shares (reported as 94,985,681) to gauge dilution or supply pressure; any further scheduled plan dates or additional 144 notices within October 2025 would be material for investor monitoring.